D. Petruzzellis

553 total citations
14 papers, 439 citations indexed

About

D. Petruzzellis is a scholar working on Epidemiology, Hepatology and Hematology. According to data from OpenAlex, D. Petruzzellis has authored 14 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Hepatology and 2 papers in Hematology. Recurrent topics in D. Petruzzellis's work include Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (5 papers). D. Petruzzellis is often cited by papers focused on Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (5 papers). D. Petruzzellis collaborates with scholars based in Italy, United States and Germany. D. Petruzzellis's co-authors include Alessandra Mangia, Valeria Piazzolla, Leonardo Mottola, Donato Bacca, Rosanna Santoro, Nicola Minerva, Alexander Thompson, John G. McHutchison, Kevin V. Shianna and Vito Carretta and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

D. Petruzzellis

14 papers receiving 425 citations

Peers

Countries citing papers authored by D. Petruzzellis

Since Specialization

Citations

This map shows the geographic impact of D. Petruzzellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Petruzzellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Petruzzellis more than expected).

Fields of papers citing papers by D. Petruzzellis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Petruzzellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Petruzzellis. The network helps show where D. Petruzzellis may publish in the future.

Co-authorship network of co-authors of D. Petruzzellis

This figure shows the co-authorship network connecting the top 25 collaborators of D. Petruzzellis. A scholar is included among the top collaborators of D. Petruzzellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Petruzzellis. D. Petruzzellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Predictors of sustained virological response 12 weeks after the end of treatment in hepatitis C virus GT3 infected patients receiving IFN-free antiviral treatments 2017 ·Journal of Hepatology ·Alessandra Mangia, Rosanna Santoro, Giovanni Cenderello, Valeria Piazzolla, D. Petruzzellis, Domenico Potenza, (unknown), (unknown), (unknown)	1
2	Mortality rate and predictors of liver disease damage in histologically diagnosed Nonalcholic Steatohepatitis: a 15 years follow-up cohort study 2017 ·Journal of Hepatology ·Alessandra Mangia, Rita Santoro, Valeria Piazzolla, Maria Maddalena Squillante, D. Petruzzellis, (unknown), M. Guido	1
3	Sustained Virological Responses (SVR) of 97% in Genotype 2 (GT-2) Patients with F3/4 Stage of Fibrosis Treated with Sofosbuvir (SOF) and Weight-Based Ribavirin (RBV): A Real Life, Single Centre Experience 2016 ·Journal of Hepatology ·Alessandra Mangia, (unknown), Valeria Piazzolla, Rosanna Santoro, D. Petruzzellis, (unknown), Maria Maddalena Squillante	1
4	1171 EFFECTS OF A NEW LIPOSOME-ENCAPSULATED FORMULATION OF SILYBIN ON HEPATITIS C VIRUS INFECTION 2013 ·Journal of Hepatology ·Maria Ripoli, Ruggero Angelico, Valeria Piazzolla, Rita Santoro, Leonardo Mottola, D. Petruzzellis, Alessandra Mangia	1
5	Limited use of interleukin 28B in the setting of response-guided treatment with detailed on-treatment virological monitoring 2011 ·Hepatology ·Alessandra Mangia, Alexander Thompson, Rosanna Santoro, Valeria Piazzolla, Massimiliano Copetti, Nicola Minerva, D. Petruzzellis, Leonardo Mottola, Donato Bacca, John G. McHutchison	50
6	851 GENETIC PREDICTORS OF STEATOSIS AND FIBROSIS IN NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 2011 ·Journal of Hepatology ·Alessandra Mangia, Leonardo Mottola, D. Petruzzellis, Valeria Piazzolla, (unknown), Rosa Di Paola, Rita Santoro, Vincenzo Trischitta, (unknown), Robert D. Fanelli, E. Vanni, Davide Seripa, Alberto Pilotto, (unknown), M. Guido, Stefano Angelo Santini	1
7	1331 LACK OF ASSOCIATION BETWEEN IL28B VARIANTS AND HBSAG CLEARANCE AFTER INTERFERON TREATMENT 2011 ·Journal of Hepatology ·Alessandra Mangia, Rita Santoro, Leonardo Mottola, M. Fasano, (unknown), Donato Bacca, Valeria Piazzolla, Vito Carretta, (unknown), (unknown), Domenico Facciorusso, D. Petruzzellis, Teresa Santantonio	5
8	Il28B Cc-Genotype Association with Hla-Dqb10301 Allele Increases the Prediction of Spontaneous HCV RNA Clearance in Thalassaemic HCV-Infected Patients 2011 ·Antiviral Therapy* ·Alessandra Mangia, Rosanna Santoro, (unknown), Leonardo Mottola, Valeria Piazzolla, D. Petruzzellis, Donato Bacca, Rocco Clemente, Massimiliano Copetti, Lazzaro Di Mauro, (unknown), Michele Sacco, (unknown)	17
9	Itpa Genetic Variants Are Protective Against Anemia During Antiviral Therapy for G2/3 Hcv, But Do Not Decrease the Need for Rbv Dose Reduction or Increase Svr 2010 ·Hepatology ·Alex J. Thompson, Rosanna Santoro, Valeria Piazzolla, (unknown), Keyur Patel, Paul J. Clark, Susanna Naggie, Kevin V. Shianna, Leonardo Mottola, D. Petruzzellis, Mario Romano, Fernando Sogari, Domenico Facciorusso, David B. Goldstein, John G. McHutchison, Alessandra Mangia	1
10	Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR 2010 ·Hepatology ·Alexander Thompson, Rosanna Santoro, Valeria Piazzolla, Paul J. Clark, Susanna Naggie, Hans L. Tillmann, Keyur Patel, Andrew J. Muir, Kevin V. Shianna, Leonardo Mottola, D. Petruzzellis, Mario Romano, Fernando Sogari, Domenico Facciorusso, David B. Goldstein, John G. McHutchison, Alessandra Mangia	58
11	An IL28B Polymorphism Determines Treatment Response of Hepatitis C Virus Genotype 2 or 3 Patients Who Do Not Achieve a Rapid Virologic Response 2010 ·Gastroenterology ·Alessandra Mangia, Alexander Thompson, Rosanna Santoro, Valeria Piazzolla, Hans L. Tillmann, Keyur Patel, Kevin V. Shianna, Leonardo Mottola, D. Petruzzellis, Donato Bacca, Vito Carretta, Nicola Minerva, David B. Goldstein, John G. McHutchison	250
12	126 PREDICTIVE ROLE OF IL28B C/C GENOTYPE ON SVR AND RVR IN PATIENTS WITH GENOTYPE 2/3 CHRONIC INFECTION 2010 ·Journal of Hepatology ·Alessandra Mangia, Alice Tompson, Rosanna Santoro, Valeria Piazzolla, Leonardo Mottola, Kevin V. Shianna, D. Petruzzellis, D. Goldstein, J. McHutchison	4
13	Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection # 2008 ·Hepatology ·Alessandra Mangia, Nicola Minerva, Donato Bacca, Raffaele Cozzolongo, (unknown), Fernando Sogari, Gaetano Scotto, F. Vinelli, Giovanni Ricci, Mario Romano, Vito Carretta, D. Petruzzellis, Angelo Andriulli	46
14	8 FACTORS PREDICTIVE OF RELAPSE IN GENOTYPE 2 AND 3 PTS TREATED FOR 12 WEEKS WITH PEGIFN ALFA 2B AND WEIGHT BASED RIBAVIRIN COMBINATION 2008 ·Journal of Hepatology ·Alessandra Mangia, (unknown), Donato Bacca, Raffaele Cozzolongo, (unknown), Fernando Sogari, F. Vinelli, Gaetano Scotto, Giorgio Ricci, Mario Romano, Vito Carretta, D. Petruzzellis, Valeria Piazzolla, Federica Di Spirito, Angelo Andriulli	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact